Environmental Exposure Clinical Trial
— PENELOPEOfficial title:
Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context: Clinical and Biological Parameters, Level of Impregnation With Endocrine Disruptors and Evaluation of the Impact of Environmental Health Measures
NCT number | NCT06083415 |
Other study ID # | RT-17 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 15, 2023 |
Est. completion date | May 15, 2027 |
Various studies show an increase in the number of cases of early puberty in girls with breast development with a variable clinical presentation and evolution. This increasing phenomenon concerns girls between 6 and 8 years old. In a large number of cases, from 70 to 95% depending on the series, no medical cause is found and environmental factors are suspected to be involved. Descriptive studies of these patients are scarce and not always provide an overview of all the parameters in line with the concept of the exposome. The PENELOPE clinical trial will allow to analyze a large number of parameters, including the adipose tissue, its metabolism, the endocrine disruptors, and the epigenetic modifications, and to study the impact of environmental health measures in the evolution of these parameters. The data from the analyses of the endocrine disruptors of the patients will be explored in parallel in experimental models (amphibians, murine, cellular) in order to test potential mechanistic hypotheses.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | May 15, 2027 |
Est. primary completion date | May 15, 2026 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 6 Years to 8 Years |
Eligibility | Inclusion Criteria: - Girls aged 6 to 8 years - Presenting a breast development (isolated or not) - Undergoing scheduled pediatric day hospital care (HDJ) - Who agree to participate in the study - Whose parents agree to their child's participation in the study - French speaking - Whose parents speak French - Affiliated to social security Exclusion Criteria: - Organic brain causes of precocious puberty: History of neurocerebral disease (malformations, developmental abnormalities) - Organic causes of precocious puberty: Mac Cune Albright syndrome, ovarian cyst or tumor and adrenal hyperplasia - History of chemotherapy or radiation therapy - Presenting with a communication disorder - Pregnancy - Persons under protective measures - Persons deprived of liberty for judicial or administrative reasons |
Country | Name | City | State |
---|---|---|---|
France | Cabinet BLM | Lambersart | Nord Pas De Calais |
France | Saint Vincent hospital | Lille | Nord Pas De Calais |
Lead Sponsor | Collaborator |
---|---|
Lille Catholic University |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline of the size of the breast development measured by Magnetic Resonance Imaging | This parameter will allow to describe the clinical evolution of breast development after application of environmental health measures | Baseline, 3 months | |
Primary | Change from baseline of the size of ovaries/uterus measured by Magnetic Resonance Imaging | This parameter will allow to describe the clinical evolution of ovaries and uterus after application of environmental health measures | Baseline, 3 months, | |
Primary | Change from baseline of the abdominal fat surface measured by Magnetic Resonance Imaging | This parameter will allow to describe the clinical evolution of the abdominal fat surface after application of environmental health measures | Baseline, 3 months | |
Primary | Change from baseline of the weight | This parameter will allow to describe the clinical evolution of the weight after application of environmental health measures | Baseline, 3 months, 6 months | |
Primary | Change from baseline of the height | This parameter will allow to describe the clinical evolution of the height after application of environmental health measures | Baseline, 3 months, 6 months | |
Primary | Body mass index (BMI) | This parameter will allow to describe the clinical evolution of the BMI after application of environmental health measures | Baseline, 3 months, 6 months | |
Secondary | Measurement of endocrine disruptors in hair | Describe the evolution of the amount of endocrine disruptors in hair after the implementation of environmental health measures. from 70 to 100 mg of hair will cut as close as possible to the scalp at the posterior vertex, and stored at room temperature to measure endocrine disruptors such as parabens, phthalates, bisphenols and pesticides. | Change from baseline at 90 days | |
Secondary | Tanner scale | The Tanner scale is a scale of physical development as children transition into adolescence and then adulthood. The scale defines physical measurements of development based on external primary and secondary sex characteristics.
Breast: Tanner I: no glandular tissue Tanner II: breast bud forms, areola begins to widen Tanner III: breast begins to become more elevated, and extends beyond the borders of the areola, Tanner IV: increased breast sizing and elevation; areola and papilla form a secondary mound projecting from the contour of the surrounding breast Tanner V: breast reaches final adult size Pubis hair: Tanner I: no pubic hair Tanner II: small amount of long, downy hair Tanner III: hair becomes more coarse and curly, and begins to extend laterally Tanner IV: adult-like hair quality, extending across pubis but sparing medial thighs Tanner V: hair extends to medial surface of the thighs |
Change from baseline at 90 and 180 days | |
Secondary | Bone age determination by X ray | Determination of bone age to determine the maturity of the child's skeletal system. | Change from baseline at 90 | |
Secondary | Degree of severity of teeth hypomineralisation | The dree of severity is determine according to a scale: 1: <30% of the tooth's enamel surface area visibly disrupted, 2: 31 to 49% of the tooth's enamel surface area visibly disrupted, 3: >50% of the tooth's enamel surface area visibly disrupted | Baseline, 3 months | |
Secondary | Follicle-stimulating hormone (FSH) level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Estradiol (E2) level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Testosterone Level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | 17 hydroxyprogesterone level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Dehydroepiandrosterone sulfate level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Sex Hormone-Binding Globulin level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Thyroid Stimulating Hormone level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | FT4 (Free Thyroxine hormone) level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Androstenedione level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Insulin level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Glycated hemoglobin (HbA1C) level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Insulin-like Growth Factor-1 level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Leptine level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Luteinizing hormone (LH) level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days | |
Secondary | Glycemia level | Blood test for determining the evolution of this parameter from baseline | Change from baseline at 90 days and 180 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05541653 -
The IGNITE Study on Concentrated Investment in Black Neighborhoods
|
N/A | |
Completed |
NCT04028791 -
Sickle Cell Trait and Exercise, Effect of Hot Environment
|
N/A | |
Not yet recruiting |
NCT05105386 -
The Impact of Synergies of Indoor Air Pollutants on Childhood Health and Wellbeing
|
||
Completed |
NCT05507944 -
FeNO Hairdressers Pilot
|
||
Completed |
NCT04146025 -
Nurtured in Nature
|
N/A | |
Recruiting |
NCT05179993 -
Detection of Microplastics in Human Granulosa Cells and in the Follicular Fluid of Women Undergoing ICSI Treatment
|
||
Completed |
NCT03444922 -
Effects of BPA on Insulin and Glucose Responses
|
N/A | |
Recruiting |
NCT03319927 -
Reducing Pesticide Exposures in Child Care Centers
|
N/A | |
Recruiting |
NCT05500690 -
Understanding Effects of Folic Acid on the Methylosome and Transcriptome of Women With Spina Bifida Affected Pregnancies
|
N/A | |
Recruiting |
NCT05394363 -
Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
|
||
Completed |
NCT00021658 -
Effects of Pesticide Exposure on Neurodevelopment/Growth/Respiratory Health
|
N/A | |
Not yet recruiting |
NCT05315388 -
Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá
|
N/A | |
Recruiting |
NCT06107933 -
Developmental Impacts of Microplastics Exposure in Early Life
|
||
Completed |
NCT03631667 -
Ultralow Dose PAH Binary Mixture Study
|
Early Phase 1 | |
Completed |
NCT02540408 -
Detection and Characterization of COPD in Dairy Farmers
|
N/A | |
Completed |
NCT03440307 -
Intervention to Reduce Bisphenol A Exposure in Women
|
N/A | |
Completed |
NCT05160948 -
Change in Knowledge After Receiving Personal Air Pollution Results
|
||
Recruiting |
NCT05865782 -
Reconstructing Schoolyards With Greenery to Increase Schoolchildren's Physical Activity and Mitigate Climate Changes
|
N/A | |
Completed |
NCT02707172 -
Removal of Dermal Exposure to Phthalate Ester by Hand Washing
|
N/A | |
Active, not recruiting |
NCT03215368 -
The Ma'Anshan Birth Cohort (MABC)
|